ProfileGDS4718 / 202969_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 97% 91% 96% 96% 93% 86% 97% 97% 97% 96% 97% 91% 88% 92% 94% 96% 90% 93% 87% 97% 97% 97% 94% 95% 92% 97% 90% 97% 91% 94% 88% 97% 98% 87% 87% 92% 97% 97% 90% 96% 86% 94% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.716896
GSM549102patient 115, normal, homogenized [OPG study]10.949397
GSM549104patient 119, normal, homogenized [OPG study]9.4601391
GSM549108patient 138, normal, homogenized [OPG study]10.689196
GSM549119patient 077, normal, homogenized [OPG study]10.769596
GSM549133patient 032, cancer, homogenized [OPG study]9.7550493
GSM549139patient 042, cancer, homogenized [OPG study]8.5913786
GSM549099patient 107, normal, homogenized [OPG study]10.986397
GSM549109patient 139, normal, homogenized [OPG study]11.202197
GSM549110patient 046, normal, homogenized [OPG study]11.037997
GSM549114patient 063, normal, homogenized [OPG study]10.873596
GSM549122patient 082, normal, homogenized [OPG study]10.94297
GSM549134patient 033, cancer, homogenized [OPG study]9.3143991
GSM549136patient 036, cancer, homogenized [OPG study]8.9047388
GSM549140patient 044, cancer, homogenized [OPG study]9.6222192
GSM549111patient 047, normal, homogenized [OPG study]10.035894
GSM549113patient 057, normal, homogenized [OPG study]10.644496
GSM549132patient 031, cancer, homogenized [OPG study]9.1056790
GSM549137patient 038, cancer, homogenized [OPG study]9.591793
GSM549142patient 047, cancer, homogenized [OPG study]8.3266687
GSM549100patient 110, normal, homogenized [OPG study]10.805297
GSM549107patient 135, normal, homogenized [OPG study]11.027497
GSM549115patient 068, normal, homogenized [OPG study]11.244697
GSM549116patient 072, normal, homogenized [OPG study]10.169394
GSM549120patient 078, normal, homogenized [OPG study]10.382295
GSM549131patient 030, cancer, homogenized [OPG study]9.6088392
GSM549118patient 074, normal, homogenized [OPG study]10.936597
GSM549129patient 027, cancer, homogenized [OPG study]9.0354790
GSM549123patient 088, normal, homogenized [OPG study]10.95997
GSM549124patient 006, cancer, homogenized [OPG study]9.2855391
GSM549126patient 015, cancer, homogenized [OPG study]9.7891694
GSM549128patient 025, cancer, homogenized [OPG study]8.8746388
GSM549103patient 117, normal, homogenized [OPG study]11.198297
GSM549117patient 073, normal, homogenized [OPG study]11.485998
GSM549138patient 041, cancer, homogenized [OPG study]8.7642987
GSM549141patient 045, cancer, homogenized [OPG study]8.8738687
GSM549130patient 028, cancer, homogenized [OPG study]9.429992
GSM549101patient 111, normal, homogenized [OPG study]11.020497
GSM549105patient 128, normal, homogenized [OPG study]10.817897
GSM549106patient 134, normal, homogenized [OPG study]9.3916290
GSM549112patient 048, normal, homogenized [OPG study]10.858396
GSM549125patient 011, cancer, homogenized [OPG study]8.5410786
GSM549127patient 024, cancer, homogenized [OPG study]9.7602694
GSM549135patient 035, cancer, homogenized [OPG study]9.6713292